LAURUSLABS

LAURUS LABS

Large Cap BSE: 540222 NSE: LAURUSLABS
₹412.7
-0.05 (-0.01%)
As on 10 December, 2022 | 14:56

Laurus Labs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in LAURUS LABS

Start SIP

Laurus Labs Share Price

Laurus Labs Share Returns

  • Over 1 Month -8.44%
  • Over 3 Month -25.7%
  • Over 6 Month -24.98%
  • Over 1 Year -20.04%

Laurus Labs Key Statistics

P/E Ratio 25.5
PEG Ratio -1.8
Market Cap Cr 22,177
Price to Book Ratio 6.6
EPS 14
Dividend 0.5
Relative Strength Index 32.12
Money Flow Index 24.97
MACD Signal -15.8
Average True Range 11.99

Laurus Labs Investment Rating

  • Master Rating:
  • Laurus Labs has an operating revenue of Rs. 5,568.42 Cr. on a trailing 12-month basis. An annual revenue growth of 2% is not great, Pre-tax margin of 22% is great, ROE of 24% is exceptional. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 7 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 129 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Laurus Labs Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 1,4981,4951,3789331,1761,2211,399
Operating Expenses Qtr Cr 1,0721,0771,005717842858936
Operating Profit Qtr Cr 426418373215334363462
Depreciation Qtr Cr 76666160595551
Interest Qtr Cr 38282921212521
Tax Qtr Cr 899664336168104
Net Profit Qtr Cr 227232221109198222293

Laurus Labs Technicals

EMA & SMA

Current Price
412.7
-0.05 (-0.01%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 435.25
  • 50 Day
  • 463.85
  • 100 Day
  • 489.26
  • 200 Day
  • 508.65
  • 20 Day
  • 439.21
  • 50 Day
  • 470.18
  • 100 Day
  • 506.23
  • 200 Day
  • 527.03

Laurus Labs Resistance and Support

PIVOT
₹414.37
Resistance
First Resistance 416.94
Second Resistance 421.12
Third Resistance 423.69
RSI 32.12
MFI 24.97
MACD Single Line -15.8
MACD -16.72
Support
First Resistance 410.19
Second Resistance 407.62
Third Resistance 403.44

Laurus Labs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,447,531 67,628,648 46.72
Week 1,600,949 82,769,043 51.7
1 Month 2,090,006 84,791,531 40.57
6 Month 1,677,338 70,800,417 42.21

Laurus Labs Result Highlights

Laurus Labs Synopsis

NSE-Medical-Diversified

Laurus Labs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 4707.04 Cr. and Equity Capital is Rs. 107.47 Cr. for the Year ended 31/03/2022. Laurus Labs Ltd. is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518.
Market Cap 22,177
Sales 5,304
Shares in Float 39.23
No of funds 256
Yield 0.48
Book Value 6.55
U/D Vol ratio 0.6
LTDebt / Equity 16
Alpha -0.1
Beta 0.96

Laurus Labs

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 27.27%27.27%27.27%
Mutual Funds 5.5%4.77%3.51%
Insurance Companies 3.48%
Foreign Portfolio Investors 22.67%21.96%22.43%
Financial Institutions/ Banks
Individual Investors 27.96%28.42%31.15%
Others 13.12%17.58%15.64%

Laurus Labs Management

Name Designation
Dr. M Venu Gopala Rao Non Exe.Chairman&Ind.Director
Dr. C V Lakshmana Rao Executive Director
Dr. Satyanarayana Chava Executive Director & CEO
Mr. V V Ravi Kumar Executive Director & CFO
Mr. Chandrakanth Chereddi Non Executive Director
Dr. Ravindranath Kancherla Independent Director
Mrs. Aruna Rajendra Bhinge Independent Director
Dr. Rajesh Koshy Chandy Independent Director

Laurus Labs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Laurus Labs Corporate Action

Date Purpose Remarks
2022-10-21 Quarterly Results & Interim Dividend
2022-07-27 Quarterly Results
2022-04-28 Audited Results & Interim Dividend
2022-01-27 Quarterly Results
2021-10-28 Quarterly Results & Interim Dividend
Date Purpose Remarks
2022-11-04 INTERIM Rs.0.80 per share(40%)Interim Dividend
2022-05-11 INTERIM Rs.1.20 per share (60%) Second Interim Dividend
2021-11-18 INTERIM Rs.0.80 per share(40%)Interim Dividend
2021-05-12 INTERIM Rs.0.80 per share (40%) Third Interim Dividend
2021-02-09 INTERIM Re.0.40 per share (20%) Second Interim Dividend
Date Purpose Remarks
2020-09-30 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

Laurus Labs MF Shareholding

Name Amount(cr)
HDFC Balanced Advantage Fund Growth 49709
Kotak Emerging Equity Scheme Growth 23224
Kotak Equity Arbitrage Fund Growth 21439
ICICI Prudential Equity Arbitrage Fund Regular Growth 10445
Mirae Asset Midcap Fund Regular Growth 8953

About Company

Laurus Labs FAQs

What is Share Price of Laurus Labs ?

Laurus Labs share price is ₹412 As on 10 December, 2022 | 14:42

What is the Market Cap of Laurus Labs ?

The Market Cap of Laurus Labs is ₹22176.8 Cr As on 10 December, 2022 | 14:42

What is the P/E ratio of Laurus Labs ?

The P/E ratio of Laurus Labs is 25.5 As on 10 December, 2022 | 14:42

What is the PB ratio of Laurus Labs ?

The PB ratio of Laurus Labs is 6.6 As on 10 December, 2022 | 14:42

Q2FY23